US Patent Issued on Feb. 3 for "Radioconjugates targeting CD33 in the treatment of cancers" (New Jersey, New York Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,340, issued on Feb. 3.

"Radioconjugates targeting CD33 in the treatment of cancers" was invented by Mary M. Chen (Hoboken, N.J.), Avinash Desai (New York), Dale L. Ludwig (Rockaway, N.J.), Mark Berger (New York) and Sandesh Seth (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating cancers and proliferative disorders, including solid tumor cancers and non-myeloid hematological malignancies, using radioconjugates targeting CD33, alone or in combination with one or more radioconjugates targeting other cancer-associated targets such as DR5, 5T4, HER2, HER3, and TROP2, antibody drug conjugat...